Accéder au contenu
MilliporeSigma

Principaux documents

Voir toute la documentation

BP578

Dexaméthasone

British Pharmacopoeia (BP) Assay Standard

Synonyme(s) :

(11β,16α)-9-Fluoro-11,17,21-trihydroxy-16-méthylpregna-1,4-diène-3,20-dione, 9α-Fluoro-16α-méthyl-11β,17α,21-trihydroxy-1,4-pregnadiène-3,20-dione, 9α-Fluoro-16α-méthylprednisolone, Prednisolone F

Se connecter pour consulter les tarifs organisationnels et contractuels.

Sélectionner une taille de conditionnement

Changer de vue

A propos de cet article

Formule empirique (notation de Hill) :
C22H29FO5
Numéro CAS:
50-02-2
Poids moléculaire :
392.46
EC Number:
200-003-9
UNSPSC Code:
41116107
NACRES:
NA.24
Beilstein/REAXYS Number:
2066651
MDL number:
MFCD00064136
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aider

grade

pharmaceutical primary standard

API family

dexamethasone

form

solid

shelf life

limited shelf life, expiry date on the label

manufacturer/tradename

BP

mp

262-264 °C (lit.)

application(s)

pharmaceutical
pharmaceutical small molecule

format

neat

storage temp.

2-8°C

SMILES string

C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO

InChI

1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1

InChI key

UREBDLICKHMUKA-CXSFZGCWSA-N

Gene Information

human ... NR3C1(2908)

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Dexamethasone BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:
  • Tobramycin and Dexamethasone Eye Drops, Suspension
  • Dexamethasone Sodium Phosphate Oral Solution
  • Hydrocortisone Sodium Succinate Injection
  • Prednisolone Tablets
  • Dexamethasone Eye Drops, Suspension
  • Dexamethasone Sodium Phosphate Eye Drops, Solution
  • Dexamethasone and Neomycin Ear Spray
  • Betamethasone Tablets
  • Dexamethasone Tablets

    • Biochem/physiol Actions

    Agent anti-inflammatoire du type glucocorticoïde
    Agent anti-inflammatoire du type glucocorticoïde. Régule la survie, la croissance et la différenciation des lymphocytes T. Inhibe l′induction de l′oxyde nitrique synthase.

    Other Notes

    Sales restrictions may apply.

    Still not finding the right product?

    Explore all of our products under Dexaméthasone

    pictograms

    Health hazard
    GHS08

    signalword

    Danger

    hcodes

    H360FD

    Hazard Classifications

    Repr. 1B

    Classe de stockage

    6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

    wgk

    WGK 3

    flash_point_f

    Not applicable

    flash_point_c

    Not applicable

    Faites votre choix parmi les versions les plus récentes :

    Certificats d'analyse (COA)

    Lot/Batch Number

    It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

    Si vous avez besoin d'assistance, veuillez contacter Service Clients

    Déjà en possession de ce produit ?

    Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

    Consulter la Bibliothèque de documents

    A Keith Stewart et al.
    The New England journal of medicine, 372(2), 142-152 (2014-12-09)
    Lenalidomide plus dexamethasone is a reference treatment for relapsed multiple myeloma. The combination of the proteasome inhibitor carfilzomib with lenalidomide and dexamethasone has shown efficacy in a phase 1 and 2 study in relapsed multiple myeloma. We randomly assigned 792
    Wei Zheng et al.
    Genes & development, 28(14), 1592-1603 (2014-07-18)
    Primitive lymphatic vessels are remodeled into functionally specialized initial and collecting lymphatics during development. Lymphatic endothelial cell (LEC) junctions in initial lymphatics transform from a zipper-like to a button-like pattern during collecting vessel development, but what regulates this process is
    Alexandre Denoyer et al.
    Ophthalmology, 122(4), 669-676 (2014-12-03)
    To compare small incision lenticule extraction (SMILE) versus LASIK for post-refractive dry eye disease. Prospective, comparative, nonrandomized clinical study. Thirty patients scheduled for bilateral myopic SMILE and 30 age-, sex-, and refraction-matched patients scheduled for bilateral myopic LASIK were enrolled
    Afficher tous les articles scientifiques apparentés

    Numéro d'article de commerce international

    RéférenceGTIN
    BP57804061835277421